Does a Blow to the Head Mean More Amyloid Down the Road?
People with previous head injuries may be more prone to amyloid deposition and have a higher risk for Alzheimer's.
314 RESULTS
Sort By:
People with previous head injuries may be more prone to amyloid deposition and have a higher risk for Alzheimer's.
New data questions whether LRRK2’s kinase activity contributes to Parkinson’s, finding instead that absolute levels of the protein matter more.
Therapeutic Approaches Target Deubiquitinase, Protein Turnover Paracrine Signal From BACE1-Clipped Neuregulin Rescues Myelin Could Longevity Factor, Epilepsy Med, Treat AD One Day? The small scientific workshop From Science to Therapeutics: The Best Way
Quick-and-Early IVIG Therapy: Hints of Promise? Anti-Amyloid Results Show Modest Benefits, Mild Side Effects Wrapping Up Enrollment, ADNI 2, PPMI Focus on Earlier Disease Drug Data Dash at AAN Annual Conference The ANN conference in San Diego covered such
Exploring Genome Fragmentation in Neurodegeneration Up-and-Coming ALS Mice Leave Scientists ConFUSed Does ALS Gene Police RNA, Keep Strands From Entangling? Does New Amyloid Protein Lend Tau a Hand? Keystone Symposium: New Frontiers in Neurodegenerative D
Microglia Activation—Venusberg Meeting Questions M1, M2 Designations Inflammatory Crosstalk Between Periphery and Brain Blessing or Curse? Peripheral Cytokines in the Brain Glial Imaging—Amid Slow Progress, EU Project Takes Up Challenge Venusberg Meeting
Combination Drug Trials: Time to Open a New Front in AD? Combination Trials: FDA Puts Flesh on Bones of Draft Guidance Combination Trials: Companies Can Play Well in One Sandbox Building a Roadmap for Shared Combination Drug Trials ACT-AD FDA/AD Allies Me
As DIAN’s Scope Widens, Funding Narrows Dominantly Inherited Alzheimer Network Pharma Consortium Meeting 2013
Meeting Explores Regulatory Requirements for Parkinson's MCI Michael J. Fox Foundation Conference
Keystone Symposia Meeting, Part 1—Alzheimer’s Disease: Genes, Cellular Pathways and Therapies Keystone Symposia Meeting, Part 2—Genetics and Epidemiology of AD Keystone Symposia Meeting, Part 3—Amyloid Precursor Protein Function Keystone Symposia Meeting,
African Americans carrying a variant in a cholesterol-processing gene have double the risk for Alzheimer’s than non-carriers...
Many researchers believe that neurodegeneration's takeover of one's brain might be driven by pathogenic, misfolded proteins spreading through interconnected neural networks...
New research reveals fundamental roles for astrocytes and microglia in shaping neural circuits.
Is transfer of tau from one neuron to the next a normal activity, hijacked by pathogenic protein in the case of tauopathies?